<it>TCF7L2 </it>and therapeutic response to sulfonylureas in patients with type 2 diabetes
<p>Abstract</p> <p>Background</p> <p>Variants in the <it>TCF7L2 </it>have been shown to be associated with an increased risk for type 2 diabetes (T2D). Since the association with diabetes could be explained by effects on insulin secretion, we investigated wh...
Saved in:
Main Authors: | Stumvoll Michael (Author), Körner Antje (Author), Hahn Michael (Author), Holstein Andreas (Author), Kovacs Peter (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2011-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
KCNJ11, ABCC8 and TCF7L2 polymorphisms and the response to sulfonylurea treatment in patients with type 2 diabetes: a bioinformatics assessment
by: Jingwen Song, et al.
Published: (2017) -
The <it>TCF7L2 </it>locus and type 1 diabetes
by: Polychronakos Constantin, et al.
Published: (2007) -
Weak or no association of <it>TCF7L2 </it>variants with Type 2 diabetes risk in an Arab population
by: Al-Daghri Nasser, et al.
Published: (2008) -
Meta-analysis of association between TCF7L2 polymorphism rs7903146 and type 2 diabetes mellitus
by: Weiyue Ding, et al.
Published: (2018) -
Consensus recommendations on sulfonylurea & sulfonylurea combinations in the management of Type 2 diabetes mellitus - international task force
by: Sanjay Kalra, et al.
Published: (2019)